APPA $1.65 $heff Portfolio Holding play as a biotech with a PDUFA date of March 18th. A forward-looking event that should move the company significantly higher.
Phase III APPA (A.P. Pharma) Trial Design…The regulatory piece (at bottom of post) is important to review w/ regards to strong chances of approval based on prior experience & knowledge of granisetron from the FDA.
Market Data 
Markets 
AI
